[1]
L. A. Lemoine and M. Segarra-Newnham, “Evaluation of outcomes of 8-week therapy with ledipasvir/sofosbuvir or glecaprevir/pibrentasvir in veterans with hepatitis C infection”, Ann Clin Gastroenterol Hepatol, vol. 3, no. 1, pp. 027–030, Nov. 2019.